nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Cognitive impairment—Dexamethasone—psoriatic arthritis	0.0405	0.0405	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Betamethasone—psoriatic arthritis	0.0405	0.0405	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Prednisone—psoriatic arthritis	0.0353	0.0353	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Methotrexate—psoriatic arthritis	0.0295	0.0295	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisolone—psoriatic arthritis	0.0288	0.0288	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methylprednisolone—psoriatic arthritis	0.0269	0.0269	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Triamcinolone—psoriatic arthritis	0.0265	0.0265	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Methylprednisolone—psoriatic arthritis	0.0264	0.0264	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Dexamethasone—psoriatic arthritis	0.0244	0.0244	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Betamethasone—psoriatic arthritis	0.0244	0.0244	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Betamethasone—psoriatic arthritis	0.024	0.024	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Dexamethasone—psoriatic arthritis	0.024	0.024	CcSEcCtD
Trihexyphenidyl—Weight decreased—Auranofin—psoriatic arthritis	0.0226	0.0226	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Prednisone—psoriatic arthritis	0.0213	0.0213	CcSEcCtD
Trihexyphenidyl—Blindness—Triamcinolone—psoriatic arthritis	0.021	0.021	CcSEcCtD
Trihexyphenidyl—Blindness—Methylprednisolone—psoriatic arthritis	0.021	0.021	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisone—psoriatic arthritis	0.0209	0.0209	CcSEcCtD
Trihexyphenidyl—Blindness—Dexamethasone—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Trihexyphenidyl—Blindness—Betamethasone—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methotrexate—psoriatic arthritis	0.0178	0.0178	CcSEcCtD
Trihexyphenidyl—Delusion—Methylprednisolone—psoriatic arthritis	0.0164	0.0164	CcSEcCtD
Trihexyphenidyl—Mydriasis—Prednisolone—psoriatic arthritis	0.0159	0.0159	CcSEcCtD
Trihexyphenidyl—Delusion—Betamethasone—psoriatic arthritis	0.0149	0.0149	CcSEcCtD
Trihexyphenidyl—Delusion—Dexamethasone—psoriatic arthritis	0.0149	0.0149	CcSEcCtD
Trihexyphenidyl—Delusion—Prednisone—psoriatic arthritis	0.013	0.013	CcSEcCtD
Trihexyphenidyl—Constipation—Auranofin—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Trihexyphenidyl—Memory impairment—Prednisone—psoriatic arthritis	0.0117	0.0117	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Triamcinolone—psoriatic arthritis	0.01	0.01	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00999	0.00999	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Betamethasone—psoriatic arthritis	0.00908	0.00908	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00908	0.00908	CcSEcCtD
Trihexyphenidyl—Vomiting—Auranofin—psoriatic arthritis	0.00901	0.00901	CcSEcCtD
Trihexyphenidyl—Rash—Auranofin—psoriatic arthritis	0.00894	0.00894	CcSEcCtD
Trihexyphenidyl—Dermatitis—Auranofin—psoriatic arthritis	0.00893	0.00893	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisolone—psoriatic arthritis	0.00843	0.00843	CcSEcCtD
Trihexyphenidyl—Nausea—Auranofin—psoriatic arthritis	0.00842	0.00842	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00824	0.00824	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Prednisone—psoriatic arthritis	0.00803	0.00803	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisone—psoriatic arthritis	0.00791	0.00791	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Betamethasone—psoriatic arthritis	0.0075	0.0075	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.0075	0.0075	CcSEcCtD
Trihexyphenidyl—Dry skin—Dexamethasone—psoriatic arthritis	0.00703	0.00703	CcSEcCtD
Trihexyphenidyl—Dry skin—Betamethasone—psoriatic arthritis	0.00703	0.00703	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Prednisone—psoriatic arthritis	0.00653	0.00653	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisone—psoriatic arthritis	0.00613	0.00613	CcSEcCtD
Trihexyphenidyl—Weight decreased—Betamethasone—psoriatic arthritis	0.006	0.006	CcSEcCtD
Trihexyphenidyl—Weight decreased—Dexamethasone—psoriatic arthritis	0.006	0.006	CcSEcCtD
Trihexyphenidyl—Hallucination—Methylprednisolone—psoriatic arthritis	0.00581	0.00581	CcSEcCtD
Trihexyphenidyl—Hallucination—Dexamethasone—psoriatic arthritis	0.00528	0.00528	CcSEcCtD
Trihexyphenidyl—Hallucination—Betamethasone—psoriatic arthritis	0.00528	0.00528	CcSEcCtD
Trihexyphenidyl—Weight decreased—Prednisone—psoriatic arthritis	0.00523	0.00523	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisolone—psoriatic arthritis	0.00522	0.00522	CcSEcCtD
Trihexyphenidyl—Hallucination—Prednisone—psoriatic arthritis	0.0046	0.0046	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisolone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Trihexyphenidyl—Drowsiness—Methotrexate—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Trihexyphenidyl—Confusional state—Methylprednisolone—psoriatic arthritis	0.00418	0.00418	CcSEcCtD
Trihexyphenidyl—Tachycardia—Triamcinolone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Trihexyphenidyl—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Trihexyphenidyl—Agitation—Prednisone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Trihexyphenidyl—Tachycardia—Betamethasone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Trihexyphenidyl—Tachycardia—Dexamethasone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Trihexyphenidyl—Vision blurred—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Trihexyphenidyl—Asthenia—Triamcinolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Trihexyphenidyl—Asthenia—Methylprednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Trihexyphenidyl—Rash—Prednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Trihexyphenidyl—Headache—Prednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Trihexyphenidyl—Constipation—Prednisone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Trihexyphenidyl—Confusional state—Methotrexate—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Trihexyphenidyl—Dizziness—Triamcinolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Trihexyphenidyl—Dizziness—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Trihexyphenidyl—Asthenia—Dexamethasone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Trihexyphenidyl—Asthenia—Betamethasone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Trihexyphenidyl—Vomiting—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Trihexyphenidyl—Vomiting—Methylprednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Trihexyphenidyl—Rash—Triamcinolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Trihexyphenidyl—Dermatitis—Triamcinolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Trihexyphenidyl—Rash—Methylprednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Trihexyphenidyl—Headache—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Trihexyphenidyl—Headache—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Trihexyphenidyl—Dizziness—Dexamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Trihexyphenidyl—Dizziness—Betamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Trihexyphenidyl—Nausea—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Trihexyphenidyl—Nausea—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Trihexyphenidyl—Somnolence—Methotrexate—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Trihexyphenidyl—Vomiting—Dexamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Trihexyphenidyl—Vomiting—Betamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Trihexyphenidyl—Rash—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Trihexyphenidyl—Rash—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Trihexyphenidyl—Dermatitis—Dexamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Trihexyphenidyl—Dermatitis—Betamethasone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Trihexyphenidyl—Headache—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Trihexyphenidyl—Headache—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Trihexyphenidyl—Asthenia—Prednisone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Trihexyphenidyl—Nausea—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Trihexyphenidyl—Nausea—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Trihexyphenidyl—Vomiting—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Trihexyphenidyl—Rash—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Trihexyphenidyl—Headache—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Trihexyphenidyl—Asthenia—Methotrexate—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Trihexyphenidyl—Dizziness—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Trihexyphenidyl—Vomiting—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Trihexyphenidyl—Rash—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Trihexyphenidyl—Headache—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Trihexyphenidyl—Nausea—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
